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Summary
Background Most childhood asthma in poor populations in Latin America is not associ-
ated with aeroallergen sensitization, an observation that could be explained by the attenu-
ation of atopy by chronic helminth infections or effects of age.
Objective To explore the effects of geohelminth infections and age on atopy, wheeze, and
the association between atopy and wheeze.
Methods A case-control study was done in 376 subjects (149 cases and 227 controls) aged
7–19 years living in rural communities in Ecuador. Wheeze cases, identified from a large
cross-sectional survey, had recent wheeze and controls were a random sample of those
without wheeze. Atopy was measured by the presence of allergen-specific IgE (asIgE) and
skin prick test (SPT) responses to house dust mite and cockroach. Geohelminth infections
were measured in stools and anti-Ascaris IgE in plasma.
Results The fraction of recent wheeze attributable to anti-Ascaris IgE was 45.9%, while
those for SPT and asIgE were 10.0% and 10.5% respectively. The association between
atopy and wheeze was greater in adolescents than children. Although Anti-Ascaris IgE
was strongly associated with wheeze (adj. OR 2.24 (95% CI 1.33–3.78, P = 0.003) and with
asIgE (adj. OR 5.34, 95% CI 2.49–11.45, P < 0.001), the association with wheeze was inde-
pendent of asIgE. There was some evidence that the association between atopy and
wheeze was greater in uninfected subjects compared with those with active geohelminth
infections.
Conclusions and clinical relevance Atopy to house dust mite and cockroach explained few
wheeze cases in our study population, while the presence of anti-Ascaris IgE was an
important risk factor. Our data provided only limited evidence that active geohelminth
infections attenuated the association between atopy and wheeze in endemic areas or that
age modified this association. The role of allergic sensitization to Ascaris in the develop-
ment of wheeze, independent of atopy, requires further investigation.
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Introduction
The International Study of Asthma and Allergies in
Childhood (ISAAC) studies have shown that childhood
asthma defined by the presence of recent wheeze is
extremely common in many Latin America countries,
where the prevalence is as high as in industrialized
countries such as UK and US [1]. In addition, asthma
prevalence is consistently higher in poor populations in
urban areas in Latin America [2, 3] compared with rural
areas [4, 5]. Possible explanations for these findings
include differences in environmental exposures associ-
ated with urbanization and the acquisition of a ‘mod-
ern’ lifestyle [1].
Asthma and atopic diseases show large differences by
age in incidence, prevalence and severity [6]. Asthma
starts during the first years of life [7], while the inci-
dence of hay fever generally peaks around school age
and adolescence in industrialized countries [8]. Sensiti-
zation to aeroallergens increases during childhood and
adolescence, reaching a peak in the third decade of life
[9, 10]. A more persistent phenotype of asthma has been
associated with atopy in late childhood and early ado-
lescence that may continue into adulthood, while early
onset asthma in the absence of atopy may be more
likely to resolve [6, 7]. Environmental triggers of atopic
diseases may mediate their effects during discrete time
windows such as the first 2 years of life and exposure to
these triggers may vary by age resulting in time and
age-dependent changes in disease incidence [11, 12].
Thus, the relationship between asthma and atopy may
differ between childhood and adolescence being associ-
ated with age-specific differences in environmental
exposures and the hormonal changes of puberty [11].
Atopy can be measured either by the presence of skin
prick test (SPT) reactivity or allergen-specific IgE (asIgE)
in serum to common aeroallergens [13]. SPT is often
preferred in large epidemiological studies because it is
easily performed, provides an immediate result, and is
commonly used to validate in vitro tests for specific IgE
[13]. However, the results of SPT and asIgE are strongly
dissociated in some populations particularly those liv-
ing in developing countries, where a significant propor-
tion of those with asIgE do not have SPT to the same
aeroallergens [14–17]. This observation has been attrib-
uted to a down-regulation of allergic effector responses
associated with environmental exposures such as infec-
tions with helminth parasites [1].
The link between asthma and atopic sensitization
increases with economic development [14]. In the
ISAAC phase II study, the population fraction of asthma
attributable (PAF) to atopy measured by SPT was 41%
in ‘affluent’ countries but only 20% in ‘non-affluent’
countries in children aged 8–12 years [14]. Similar
results were obtained when the presence of specific IgE
to common aeroallergens (asIgE) was used to define
atopy (45.6% vs. 18.3% respectively) [14] Moreover, in
the two Latin American study centres included in the
ISAAC Phase II study (Pichincha Province, Ecuador and
Uruguaiana, Brazil), only 11% of asthma was attribut-
able to SPT [14], while a study of children of the same
age living in rural Esmeraldas Province in Ecuador
showed that only 2.4% of asthma was attributable to
SPT [18]. The weak associations between asthma and
atopy in such populations could be explained by the
attenuation of atopy or Th2-mediated allergic responses
by environmental factors including chronic helminth
infections [19, 20].
To investigate the effects of geohelminth infections
and age on atopy, wheeze, and the association between
atopy and wheeze, we conducted a case-control study
of recent wheeze in school-age children and adolescents
living in a rural area of tropical Ecuador.
Methods
Study area and population
The study was conducted among school children and
adolescents in rural Afro-Ecuadorian communities in
the districts of Eloy Alfaro and San Lorenzo, in Esmer-
aldas province, Northeastern Ecuador. The characteris-
tics of the study area and population have been
described in detail elsewhere [21].
Study design
Between March 2005 and May 2007, a cross-sectional
survey was conducted among 3960 school children
between 6 and 16 years of age [18]. Within this study
population, a nested case-control study was performed
between November 2007 and March 2009, with wheeze
cases selected from the population based on the presence
of recent wheeze and controls as a random sample of
those without symptoms. Individuals considered eligible
to be cases were those with a positive (parental) response
to the question, ‘Has your child had wheeze in the chest
in the last 12 months?’ (‘El nin˜o(a) ha tenido silbido al
pecho en los ultimos 12 meses?’), in the cross-sectional
survey and eligible controls were those individuals with
a negative response to the question, ‘Has your child ever
had wheeze in the chest? (Alguna vez en la vida, el nin˜o
(a) tuvo silbido al pecho (en cualquier epoca del pasa-
do?)’. At the time of selection of cases and controls, a
brief screening questionnaire was administered again to
parents. Cases were those children for whom a second
positive parental response was obtained to the first ques-
tion. Four controls for each case were selected from ran-
dom lists generated using Stata 9 software (Statacorp,
College Station, TX, USA) and were eligible if a second
negative response was obtained to the second question.
Individuals with inconsistent responses for the two ques-
tions in the two questionnaires were excluded. The time
between the cross-sectional and screening questionnaires
was approximately 2 years.
Sample size and study power
A pilot study estimated the prevalence of wheeze within
the previous 12 months and SPT in rural area as being
7.3% and 13.5% respectively. We estimated that a sam-
ple of 4000 children in the rural area would be needed
to obtain 292 wheeze cases or 200 cases with losses of
30% and 800 controls (case-control ratio 1 : 4) to
detect an effect on wheeze of OR < 0.6 for common
exposures (40–60% prevalence – e.g. geohelminth
infections and household pets), and OR < 0.4 for rare
exposures (10% – e.g. family history of allergic disease)
with a study power of 80% and P < 0.05 [21].
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Questionnaire
A questionnaire was administered to the child’s parent
or guardian in the presence of the child that included
the core allergy questions of the ISAAC phase II study
[22] and supplementary questions, including a detailed
history of asthma, rhinitis and eczema symptoms, the
management of asthma and potential risk factors [21,
22].
IgE measurements
Blood samples (7 mL) were collected by venipuncture
from participants, centrifuged and plasma was stored
at – 20°C until testing. Total IgE and IgE antibodies
specific for Dermatophagoides pteronyssinus, Periplan-
eta americana (American cockroach) and Ascaris
lumbricoides were measured using the Pharmacia CAP
system (Phadia AB, Uppsala, Sweden) according to the
manufacturer’s instructions. Measurements of asIgE
were restricted to D. pteronyssinus and P. americana.
We analysed asIgE in three ways: (1) asIgE level: the
highest concentration of asIgE observed for either
mite or cockroach; (2) asIgE category: the highest
concentration of asIgE observed for either mite or
cockroach within the following ranges, < 0.70,
 0.70–3.49, and  3.5 kU/L; (3) asIgE positivity:
having any asIgE  0.70 kU/L. Levels of total IgE
were loge-transformed and expressed as geometric
means.
Allergen skin prick testing
Allergic sensitization was measured by skin prick test-
ing with seven allergen extracts (Greer laboratories, Le-
noir, NC, USA): D. pteronyssinus/farinae mix, American
cockroach (P. americana), Alternaria tenuis, cat dog, ‘9
southern grass mix’ and ‘New stock fungi mix’, positive
histamine and negative saline controls. A positive reac-
tion was defined as a mean weal diameter at least
3 mm greater than the saline control 15 min after
pricking the allergen onto the volar side of the forearm
using ALK lancets (ALK, Hungerford, UK). For the pur-
poses of analysis, only those children with positive
SPTs to cockroach and mite were considered to be SPT
positive.
Stool examinations
Single stool samples were collected and analysed for
geohelminth eggs and larvae using the modified Kato
Katz (quantification of A. lumbricoides and Trichuris
trichiura) and formol-ether concentration (detection of
all geohelminths including hookworm and Strongyloides
stercoralis) methods [23]. As stool eggs counts were
over-dispersed, they were loge-transformed and
expressed as geometric means.
Exercise-induced bronchospasm
Each child underwent a vigorous six-minute free run-
ning exercise with spirometry performed before and
five minutes after exercise as described previously [21].
The highest forced expiratory volume in 1 s (FEV1)
from five efforts before and after the exercise were used
to measure exercise-induced bronchospasm (EIB) as fol-
lows: [(Pre-exercise FEV1  Post-exercise FEV1)/(Pre-
exercise FEV1)] 9 100. For the purposes of this study,
EIB was defined as a fall of 10% in FEV1 after exercise.
The heart rate before and after exercise was recorded as
a measure of the intensity of the exercise.
Statistical analysis
Differences in the prevalence of asIgE ( 0.70 kU/L),
SPT and geohelminth infection markers between cases
and controls were evaluated using v2 or Fisher’s exact
test where appropriate. Population attributable fractions
(PAFs) were calculated using the formula
P 9 (OR  1)/OR where P is the prevalence of SPT or
asIgE among children with recent wheeze. We evaluated
the effects of age [childhood (7–11 years) vs. adoles-
cence (12–19 years)] with the cut-off defined by the
median age of 12 years on atopy and wheeze as fol-
lows: (1) A Venn diagram was used to display the dis-
tribution of asIgE and SPT responses in asthmatic cases
and non-asthmatic controls by age group; and (2) the
associations of asIgE, SPT and anti-Ascaris IgE with
wheeze were estimated for each of the two age groups
using random effects logistic regression allowing
adjustment for clustering. ORs were adjusted for sex,
maternal allergic diseases and maternal smoking.
Geohelminth infections or exposures may act as
effect modifiers of the associations between markers of
atopy and wheeze. The potential effects of markers of
geohelminth infection (positive stool samples for A.
lumbricoides and/or T. trichiura and presence of anti-
Ascaris IgE [ 0.7 kU/L) on the following associations
were assessed using random effects logistic regression
or logistic regression models with the ‘survey’ estima-
tion (to take in account the effect of case-control design
and two-level data structure) where appropriate: (1) SPT
and recent wheeze; (2) asIgE and recent wheeze; and (3)
asIgE and SPT. Models were built separately for pres-
ence or absence of geohelminth infections in stools and
for presence or absence of anti-Ascaris IgE. We used
hierarchical analyses to explore whether associations
between anti-Ascaris IgE and wheeze might be
explained by asIgE (i.e. by treating asIgE as an interme-
diate variable in the association between anti-Ascaris
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IgE and wheeze). For this analysis, the ORs for the mod-
els that exclude and include asIgE are compared – if
inclusion reduces the OR towards 1 then this suggest
that part of the association may be explained by asIgE.
In addition, we evaluated the effects of the two geo-
helminth infection markers on wheeze, asIgE, and SPT
and their joint effects through stratification into four
groups: (1) no active infection or IgE sensitization to
Ascaris (geohelminth ova negative and absence of anti-
Ascaris IgE), (2) active infection without IgE sensitiza-
tion to Ascaris (ova positive and absence of anti-Asca-
ris IgE), (3) no active infection but evidence of IgE
sensitization to Ascaris (ova negative and presence of
anti-Ascaris IgE), (4) active infection in the presence of
IgE sensitization to Ascaris (ova positive and presence
of anti-Ascaris IgE). Atopic wheeze was defined by
wheeze within the previous 12 months in the presence
of asIgE ( 0.70 kU/L) to either house dust mite and
or cockroach. Multivariate multinomial logistic regres-
sion was used to estimate the association between the
markers of geohelminth infection and wheezing among
non-atopic children (by comparing non-atopic wheezers
with non-atopic non-wheezers) and for wheezing
among atopic children (by comparing atopic wheezers
with atopic non-wheezers). All models were adjusted
for a priori confounders of age, sex, maternal allergic
diseases and maternal smoking (for wheeze outcomes
only). Analyses stratified by exposure levels for which
separate ORs were estimated were adjusted for a priori
confounders only because of issues of convergence.
Overall analyses for study outcome-exposure associa-
tions were adjusted for other confounders using a back-
ward stepwise procedure in which individual covariates
were kept in the models if they were significant predic-
tors of the outcome (at P < 0.05) or if they altered OR
for the outcome by > 10%. The potential confounders
considered were body mass index, day care attendance,
household pet exposures, breastfeeding, sedentarism
(exercise levels and time spent watching TV), maternal
educational level, source of drinking water, excreta dis-
posal and crowding. All analyses were done using STA-
TA, version 10 (Statacorp).
Ethics
The study was approved by the ethics committee of the
Hospital Pedro Vicente Maldonado, Ecuador (9-12-04),
and the study was conducted in accordance with the
principles expressed in the Declaration of Helsinki.
Written informed consent was obtained from the parent
of each child and signed minor assent from the child.
The parent or guardian of each child was provided with
a copy of all laboratory results, and all children with
geohelminth infections were offered appropriate
treatment.
Results
Characteristics of study population
A total of 839 children (154 cases and 685 controls)
were recruited in the case-control study. The data
included in the present analysis were from a sample of
379 of these children for whom measurement were
done of asIgE, total IgE and anti-Ascaris IgE in
plasma. This sample included 150 (97.4%) of the 154
asthma cases and a random sample of controls [229/
685 (33.4%)]. The number of children with complete
data for recent wheeze and markers of atopy was 376
(149 cases and 227 controls) and with data for geo-
helminth infections also was 363 (142 cases and 221
controls). The characteristics of cases and controls are
shown in Table 1. Among infected children, the geo-
metric mean infection intensity for A. lumbricoides
was 2587 eggs per gram (epg) of feces (range, 70–
169, 400) and 785 epg (range, 70–83, 650) for T. trich-
iura, and did not vary between cases and controls.
Geometric mean levels of total IgE (668 vs. 427 IU/mL,
P = 0.002) and specific IgE for Ascaris (2.96 vs.
1.45 kU/L, P < 0.0001) and D. pteronyssinus (0.72 vs.
0.50 kU/L, P = 0.003) were significantly greater in
cases than controls, but there were no differences in
levels of specific IgE for P. americana (0.50 vs.
0.47 kU/L, P = 0.41). The PAFs for recent wheeze asso-
ciated with detectable levels of asIgE and SPT were
10.5% and 10.0%, respectively, while that for anti-
Ascaris IgE was 45.9%.
Effect of age on associations between wheeze and atopy
The proportional Venn diagram (Figure 1) showed that
a substantial and similar proportion of children aged 7
–11 years with (cases) and without (controls) recent
wheeze (69.7% vs. 73.3%, respectively) had no evi-
dence of atopy (as measured using either SPT or asIgE
to D. pteronyssinus and P. americana). Among adoles-
cents aged 12–19 years, 51.7% of cases and 70.1% of
controls had no evidence of atopy. The second most
frequent category for both cases and controls was asI-
gE (in the absence of SPT), and this proportion
increased with age in cases (i.e. 7–11 years, 15.7% vs.
12–19 years, 21.7%) and controls (7–11 years 13.3%
vs. 12–19 years, 17.5%). There was a greater overlap of
the two markers of atopy among cases than controls in
both age groups. Relatively low concordances were
observed between the two markers of atopy in cases
and controls (j = 0.423 and 0.363 respectively).
Among all children, only 44.9% (22/49) of cases with
asIgE had a positive SPT, while 75.9% (22/29) of cases
with positive SPT had asIgE. The respective proportions
among controls were 35.7% (20/56) and 69.0% (20/29)
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respectively. The associations between markers of atopy
and recent wheeze by age grouping are shown in
Table 2. The prevalence of SPT was associated with an
increased risk of wheeze in the older but not in the
younger age group (adj. OR 2.99, 95% CI 1.31–6.80,
P = 0.009 vs. adj. OR 1.20, CI 0.48–2.99, P = 0.697). In
the case of specific allergens, SPT to D. pteronyssinus
was significantly associated with wheeze in the older
age group (adj. OR 2.76, 95% CI 1.07–7.13, P = 0.036),
but there was no association between SPT to P. ameri-
cana and wheeze in either age group. An association
between wheeze and asIgE was observed in the older
age group only among children with high levels of asI-
gE ( 3.5 kU/L) (adj. OR 3.90, 95% CI 1.39–10.96,
P = 0.010). For specific allergens, IgE to D. pteronyssi-
nus and P. americana was not significantly associated
with wheeze in either age group. There was no evi-
dence for a statistically significant interaction between
age and atopy on the risk of wheeze (P-values for
interaction for SPT and asIgE, 0.368 and 0.234 respec-
tively). The presence of specific IgE to A. lumbricoides
was significantly associated with wheeze in both age
groups (7–11 years, adj. OR 2.06, 95% CI 1.05–4.03,
P = 0.035 vs. 12–19 years, adj. OR 3.00, 95% CI 1.37–
6.56, P = 0.006). There was no difference in the preva-
lence of A.lumbricoides or other geohelminths between
cases and controls in either age group (data not
shown).
Effects of geohelminth infections on associations
between atopy and wheeze
Geohelminth infections or exposures may act as effect
modifiers of the associations between markers of atopy
and wheeze. The presence of active geohelminth infec-
tions appeared to reduce the size of the ORs for the
associations between SPT and wheeze (Table 3; No geo-
helminths [negative], adj. OR 3.52, 95% CI 1.05–11.79,
P = 0.041 vs. any geohelminth [positive] adj. OR 1.59,
95% 0.72–3.54, P = 0.253), although there was not sta-
tistical evidence for interaction (P = 0.366). There was
some limited evidence also that children with active
geohelminth infections had a weaker association
between asIgE and wheeze (Table 3). In the case of
anti-Ascaris IgE, the association between SPT and
wheeze did not appear to be affected (Table 3), but
there was some evidence that children without anti-
Ascaris IgE had a stronger association between asIgE
and wheeze compared with those with anti- Ascaris
IgE. Inclusion of anti-Ascaris IgE, but not active geo-
helminth infections, as a variable in the model for the
association between asIgE and wheeze (data no shown),
resulted in a decrease in OR (without anti-Ascaris IgE,
adj. OR 1.47, 95% IC 0.89–2.41, P = 0.131 vs. with
anti-Ascaris IgE, adj. OR 1.18, 95% CI 0.70–1.98,
Table 1. Characteristics of cases and controls
Cases Controls
P-value*Variables n = 149 n = 227
Age (years)
7–10 59 (39.6%) 56 (24.7%)
11–14 70 (47.0%) 110 (48.5%)
15–19 20 (13.4%) 61 (26.9%) 0.001
Sex
Male 83 (55.7%) 129 (56.8%)
Female 66 (44.3%) 98 (43.2%) 0.830
Maternal education level [5]
Complete secondary or higher 14 (9.4%) 16 (7.2%)
Complete primary or
incomplete secondary
55 (36.9%) 94 (42.3%)
Illiterate or incomplete primary 80 (53.7%) 112 (50.5%) 0.506
Excreta disposal
Toilet or latrine 85 (57.1%) 136 (59.9%)
Open field 64 (42.9%) 91 (40.1%) 0.581
Birth order
1st–3rd 58 (38.9%) 78 (34.4%)
 4th 91 (61.1%) 149 (65.6%) 0.368
Maternal allergic diseases
No 60 (40.3%) 162 (71.4%)
Yes 89 (59.7%) 65 (28.6%) < 0.001
Maternal smoking
No 118 (79.2%) 193 (85.0%)
Yes 31 (20.8%) 34 (15.0%) 0.144
Skin prick reaction
Any allergen (dust
mite or cockroach)
Negative (< 3 mm) 120 (80.5%) 198 (87.2%)
Positive ( 3 mm) 29 (19.5%) 29 (12.8%) 0.079
Dust mite 21 (14.1%) 18 (7.9%) 0.055
Cockroach 10 (6.7%) 15 (6.6%) 0.969
Grass mix 1 (0.7%) 3 (1.3%) 0.548
Cat 2 (1.3%) 1 (0.4%) 0.336
Dog 1 (0.7%) 0 (0.0%) 0.216
Fungi 0 (0.0%) 0 (0.0%)
Alternaria 0 (0.0%) 1 (0.4%) 0.417
Allergen specific IgE (asIgE)
Any asIgE (dust mite or cockroach)
Negative (< 0.70 kU/L) 100 (67.1%) 171 (75.3%)
Positive ( 0.70 kU/L) 49 (32.9%) 56 (24.7%) 0.082
Any asIgE levels (dust mite or cockroach)
< 0.70 kU/L 100 (67.1%) 171 (76.2%)
0.70–3.49 kU/L 25 (16.8%) 42 (18.5%)
 3.50 kU/L 24 (16.1%) 14 (6.2%) 0.007
IgE to dust mite ( 0.70 kU/L) 34 (22.8%) 38 (16.7%) 0.143
IgE to cockroach ( 0.70 kU/L) 26 (17.5%) 31 (13.7%) 0.316
Anti-Ascaris IgE ( 0.70 kU/L) 115 (77.2%) 130 (57.3%) < 0.001
Exercise-Induced Bronchospasm [14]
No 121 (85.8%) 213 (96.4%)
Yes 20 (14.2%) 8 (3.6%) < 0.001
Geohelminth infections [13]
Any geohelminth 64 (74.4%) 65 (73.0%) 0.835
Ascaris lumbricoides 65 (45.8%) 105 (47.5%) 0.746
Trichuris trichiura 82 (57.8%) 129 (58.4%) 0.906
Hookworm 9 (6.3%) 20 (9.1%) 0.352
Strongyloides stercoralis 0 (0.0%) 1 (0.5%) 0.422
*Comparison of cases and control subjects: X2 or Fisher’s exact test.
Number of missing values are given in parentheses.
Exercise-Induced Bronchospasm: 10% fall in FEV1 after exercise.
© 2012 Blackwell Publishing Ltd, Clinical & Experimental Allergy, 43 : 60–72
64 A.-L. Moncayo et al
P = 0.530) suggesting that part of the association may
be explained by anti-Ascaris IgE.
Effect of geohelminth infections on associations between
asIgE and SPT
Geohelminth infections or IgE sensitization to A. lumb-
ricoides could modify the association between asIgE
and SPT. A significantly weaker association between as-
IgE and SPT was observed among children with anti-
Ascaris IgE compared with those without (adj. OR 8.80,
95% CI 2.64–29.28, P = 0.001 vs. adj. OR 44.19, 95%
CI 3.40–373.80, P = 0.005; test for interaction,
P = 0.016), but the presence of active geohelminth
infections did not markedly alter this association
(Table 4). The association between asIgE and SPT was
altered little by controlling for the effects of anti-Asca-
ris IgE (without anti-Ascaris IgE, adj. OR 11.03, 95% CI
4.42–27.53, P < 0.001 vs. with adj. OR 13.83, 95% CI
4.85–39.42, P < 0.001), suggesting that cross-reactivity
between asIgE and anti-Ascaris IgE is an unlikely
explanation for the dissociation between the results of
asIgE and SPT.
Associations between markers of geohelminth infection
and atopy/wheeze
The associations between geohelminth infection markers
and study outcomes are shown in Table 5. Children
with anti-Ascaris IgE had a higher prevalence of recent
wheeze (adj. OR 2.24, 95% CI 1.33–3.78, P = 0.003) and
asIgE (adj. OR 5.34, 95% CI 2.49–11.45, P < 0.001). The
effect on wheeze was affected little by adjustment for
asIgE (inclusion of asIgE in model, adj. OR 2.13, 95%
CI 1.24–3.66, P = 0.006), suggesting that the effects of
anti-Ascaris IgE on wheeze cannot be explained by asI-
gE. Although anti-Ascaris IgE was positively associated
with EIB, this effect was not significant (adj. OR 5.03,
95% CI 0.22–112.90, P = 0.305). The presence of anti-
Ascaris IgE was strongly associated with atopic wheeze
(i.e. defined by recent wheeze with asIgE  0.70 kU/L)
(adj. OR 6.98, 95% CI 2.69–18.08, P = 0.001) and also
significantly associated with non-atopic wheeze (adj.
OR 2.67, 95% CI 1.48–4.81, P < 0.001). On the other
hand, active infections with any geohelminth or A.
lumbricoides alone were not associated with wheeze or
atopy, but children with T. trichiura infections had a
Fig. 1. Proportional Venn Diagrams for the overlap between allergen specific IgE (asIgE  0.70 kU/L) and allergen skin prick test (SPT) responses
in cases and controls by age grouping (N = 376). Within each diagram, the circles show the proportions of cases or controls with asIgE or SPT
responses or where the circles overlap, the proportions with both atopic markers. Areas within the diagram but outside the circles represent the
proportions with no positive atopic marker (no atopy) for either cases (wheeze) or controls (no wheeze).
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significantly reduced prevalence of atopic wheeze (adj.
OR 0.47, 95% CI 0.22–0.98, P = 0.043), an observation
that was reflected in a strong inverse association
between T. trichiura infection and the prevalence of
SPT (adj. OR 0.42, 95% CI 0.17–0.99, P = 0.053).
To explore the effects of active infections vs. IgE sen-
sitization to Ascaris on study outcomes, we stratified
the children into four infection groups according to the
presence and absence of geohelminth infections and
anti-Ascaris IgE (Table 5). The four-group stratification
showed significant associations between the presence of
anti-Ascaris IgE and recent wheeze, the presence of asI-
gE, and atopic and non-atopic wheeze (Table 5) that
was independent of the presence of geohelminth ova in
stool samples. No significant associations with study
outcomes were observed among children without anti-
Ascaris IgE.
Discussion
Childhood asthma has emerged as a major public health
problem in many Latin American countries [1],
although there are marked differences in asthma preva-
lence and morbidity between and within countries, par-
ticularly between urban and rural populations [24, 25].
The causes of regional differences in asthma prevalence
are likely to reflect distinct patterns of environmental
exposures interacting with genetic factors. Atopy is
Table 2. Associations of recent wheeze (cases) with allergen specific IgE (asIgE) and skin prick test reactivity (SPT) to house dust mite and cock-
roach and anti-Ascaris IgE
7–11 years (n = 179) 12–19 years (n = 197) Total (N = 376)
PAF (%)Variables N
Wheeze
n(%) OR (95% CI)* N Wheeze n(%) OR (95% CI)* N
Wheeze
n(%) OR (95% CI)†
Any asIgE levels (kU/L)
< 0.70 134 64 (48.1) 1.0 137 36 (26.3) 1.0 273 100 (36.6) 1.0
0.70–3.49 26 12 (46.2) 0.75 (0.30–1.86) 41 13 (31.7) 1.22 (0.55–2.72) 65 25 (38.5) 1.00 (0.54–1.81) 0.80
P = 0.534 P = 0.620 0.979
 3.50 19 13 (68.4) 1.92 (0.64–5.75) 19 11 (57.9) 3.80 (1.35–10.76) 38 24 (63.2) 2.84 (1.34–6.06) 10.44
P = 0.242 P = 0.011 0.007
Any asIgE ( 0.70 kU/L)
Negative 134 64 (47.8) 1.0 137 36 (26.3) 1.0 271 100 (36.9) 1.0
Positive 45 25 (55.6) 1.10 (0.53–2.29) 60 24 (40.0) 1.79 (0.91–3.52) 105 49 (46.7) 1.47 (0.89–2.41) 10.52
P = 0.805 P = 0.089 P = 0.131
asIgE to HDM ( 0.70 kU/L)
Negative 152 73 (48.0) 1.0 152 42 (27.6) 1.0 304 115 (37.8) 1.0
Positive 27 16 (59.3) 1.38 (0.56–3.39) 45 18 (40.0) 1.77 (0.86–3.68) 72 34 (47.2) 1.64 (0.93–2.89) 8.91
P = 0.488 P=0.123 P = 0.087
asIgE to cockroach ( 0.70 kU/L)
Negative 151 74 (49.0) 1.0 168 49 (29.2) 1.0 319 123 (38.6) 1.0
Positive 28 15 (53.6) 0.97 (0.41–2.31) 29 11 (37.9) 1.46 (0.61–3.47) 17 26 (45.6) 1.20 (0.65–2.23) 2.91
P = 0.949 P = 0.396 P = 0.558
Anti-Ascaris IgE ( 0.70 kU/L)
Negative 67 23 (34.3) 1.0 64 11 (17.2) 1.0 131 34 (26.0) 1.0
Positive 112 66 (58.9) 2.06 (1.05–4.03) 133 49 (36.8) 3.00 (1.37–6.56) 245 115 (46.9) 2.47 (1.50–4.07) 45.93
P = 0.035 P = 0.006 P < 0.001
Any SPT ( 3 mm)
Negative 154 76 (49.4) 1.0 164 44 (26.8) 1.0 318 120 (37.7) 1.0
Positive 25 13 (52.0) 1.20 (0.48–2.99) 33 16 (48.5) 2.99 (1.31–6.80) 58 29 (50.0) 2.05 (1.11–3.78) 9.97
P = 0.697 P = 0.009 P = 0.022
SPT to HDM ( 3 mm)
Negative 162 79 (48.8) 1.0 175 49 (28.0) 1.0 337 128 (38.0) 1.0
Positive 17 10 (58.8) 1.40 (0.47–4.21) 22 11 (50.0) 2.76 (1.07–7.13) 39 21 (53.9) 2.15 (1.04–4.42) 7.54
P = 0.545 P = 0.036 P = 0.038
SPT to cockroach ( 3 mm)
Negative 169 85 (50.3) 1.0 182 54 (29.7) 1.0 351 139 (39.6) 1.0
Positive 10 4 (40.0) 0.80 (0.19–3.33) 15 6 (40.0) 1.91 (0.61–6.03) 25 10 (40.0) 1.37 (0.56–3.34) 1.81
P = 0.763 P = 0.269 P = 0.494
*OR estimated by random effects logistic regression model and adjusted by sex, maternal allergic diseases, maternal smoking.
†OR estimated by random effects logistic regression model and adjusted by age, sex, maternal allergic diseases, maternal smoking.
Any SPT/Any asIgE – SPT or specific IgE for either mite or cockroach.
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considered an important determinant of the prevalence
[14] and severity [26] of childhood asthma in industri-
alized countries; however, population-based studies of
children and adolescents aged 4–16 years with asthma
symptoms [18, 27, 28] and bronchial hyperresponsive-
ness [29] in Latin America have shown only weak asso-
ciations with atopy. Thus, the factors that modify the
association between atopy and asthma and that affect
the prevalence of atopy in Latin American populations
are of public health relevance.
Over recent years, there has been interest in the role
of geohelminth infections in affecting atopy and
asthma prevalence although the findings of studies
have been inconsistent [19]. In the present case-control
analysis, we explored the effects of age and geohelm-
inth infections on the association between atopy and
Table 3. Associations of wheeze with allergen specific IgE (asIgE) and skin prick test reactivity (SPT) to house dust mite and cockroach stratified
by presence of the geohelminth infection markers, Ascaris lumbricoides and/or Trichuris trichiura or anti-Ascaris IgE
A. lumbricoides and or T. trichiura infection
Negative (n=112) Positive (n=251)
Wheeze
n(%)/N OR (95% CI) P-value
Wheeze
n(%)/N OR (95% CI) P-value
Any asIgE levels (kU/L)
< 0.70 23 (31.9)/72 1.0 73 (38.6)/189 1.0
 0.70 19 (47.5)/40 2.23 (0.81–6.16) 0.123 27 (43.6)/62 1.05 (0.56–1.98) 0.870
Any SPT
Negative 29 (33.3)/87 1.0 85 (38.8)/219 1.0
Positive 13 (52.0)/25 3.52 (1.05–11.79) 0.041 15 (46.9)/32 1.59 (0.72–3.54) 0.253
Anti-Ascaris IgE (kU/L)
< 0.70 (n = 131)  0.70 (n = 245)
Wheeze
n(%)/N OR (95% CI) P-value
Wheeze
n(%)/N OR (95% CI) P-value
Any asIgE levels (kU/L)
< 0.70 28 (24.1)/116 1.0 72 (46.5)/155 1.0
 0.70 6 (40.0)/15 2.88 (0.84-9.88) 0.093 43 (47.8)/90 1.00 (0.56-1.76) 0.993
Any SPT
Negative 28 (24.6)/114 1.0 92 (45.1)/204 1.0
Positive 6 (35.3)/17 2.53 (0.77–8.27) 0.125 23 (56.1)/41 1.96 (0.93–4.12) 0.075
ORs estimated by random effects logistic regression and adjusted by age, sex, maternal smoking and maternal allergic diseases.
Table 4. Association between allergen specific IgE (asIgE) and skin prick test reactivity (SPT) to house dust mite and cockroach stratified by pres-
ence and absence of A. lumbricoides and/or T. trichiura infection or anti-Ascaris IgE
A. lumbricoides and or T. trichiura infection
Negative (n=112) Positive (n=251)
SPT Positive
n(%)/N OR (95% CI) P-value
SPT Positive
n(%)/N OR (95% CI) P-value
Any asIgE levels (kU/L)
< 0.70 6 (8.33)/72 1.0 10 (5.3)/189 1.0
 0.70 15 (47.5)/40 14.04 (3.44–57.29) <0.001 22 (35.5)/62 9.16 (2.39–35.07) 0.002
Anti-Ascaris IgE (kU/L)
< 0.70 (n = 131)  0.70 (n = 245)
SPT positive
n(%)/N OR (95% CI) P-value
SPT positive
n(%)/N OR (95% CI) P-value
Any asIgE (kU/L)
< 0.70 6 (5.2)/116 1.0 10 (6.5)/155 1.0
 0.70 11 (73.3)/15 44.19 (3.40–373.80) 0.005 31 (34.4)/90 8.80 (2.64–29.28) 0.001
ORs estimated by logistic regression model with survey estimation and adjusted by age, sex and maternal allergic diseases.
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recent wheeze in school-age children living in a rural
area of Ecuador. Less than a third of children with
wheeze had evidence of atopy to the dominant sensitiz-
ing allergens in our study population, house dust mite
and cockroach, whereas this proportion increased to
half among adolescents. Further, the association
between atopy and wheeze was stronger in adolescents
compared with children. IgE sensitization to Ascaris but
not active geohelminth infections (measured by the
presence of eggs in stool samples) increased the risk of
wheeze in children and adolescents independently of
asIgE. The fraction of wheeze that was attributable to
anti-Ascaris IgE in our study population was 45.9%,
while the attributable fractions for asIgE and SPT were
just 10.5% and 10.0% respectively. These data strongly
support an important role for allergic sensitization to
Ascaris as a risk factor for wheeze.
Asthma during childhood is complex and has differ-
ent characteristics at different ages, perhaps as a conse-
quence of the influence of environmental exposures,
that may vary by age, on underlying genetic suscepti-
bilities [30]. Cohort studies have demonstrated that
transient wheeze and non-atopic wheeze phenotypes
predominate during the first years of life and mid-
childhood respectively. Persistent wheeze, more com-
monly associated with atopy and airways hyperrespon-
siveness, tends to appear in late childhood and early
adolescence and may continue into adulthood [7]. In
our study population, there was some evidence that the
association between wheeze and atopy increased with
age. Previous studies in children and adolescents in
underprivileged populations in Latin America have
shown weak associations between atopy and wheeze/
asthma [2, 18, 27, 28], while a study in adults [31]
showed a moderate to high association indicating that
the age of the study population could be a possible
explanation for differences between studies. Genetic
studies have addressed the influence of age on the
development of atopy and asthma [6], and have identi-
fied distinct susceptibility genes that are associated with
childhood and adult asthma [32, 33]. Adolescence is
characterized by rapid hormonal, physical and behavio-
ural changes, all of which may affect the natural course
of asthma. Sex hormones can alter b2-adrenergic
Table 5. Associations of markers of geohelminth infection with wheeze, and presence of skin prick test reactivity (SPT) and allergen specific IgE
(asIgE) to house dust mite and cockroach
Wheeze
OR (CI 95%)
SPT ( 3 mm)
OR (CI 95%)
asIgE
OR (CI 95%)
Atopic wheeze
OR (CI 95%)
Non-atopic wheeze
OR (CI 95%)
Anti-Ascaris IgE
< 0.70 kU/L 1.0 1.0 1.0 1.0 1.0
 0.70 kU/L 2.24 (1.33–3.78) 1.15 (0.45–2.95) 5.34 (2.49–11.45) 6.98 (2.69–18.08) 2.67 (1.48–4.81)
P=0.003 P = 0.761 P < 0.001 P = 0.001 P < 0.001
A. lumbricoides infection
Negative 1.0 1.0 1.0 1.0 1.0
Positive 0.90 (0.55-1.48) 0.82 (0.41–1.64) 0.86 (0.53–1.41) 0.76 (0.37–1.55) 0.99 (0.57–1.73)
P = 0.680 P = 0.570 P = 0.549 P = 0.447 P = 0.976
T. trchiura infection
Negative 1.0 1.0 1.0 1.0 1.0
Positive 0.72 (0.44–1.18) 0.42 (0.17–0.99) 0.78 (0.47–1.28) 0.47 (0.22–0.98) 0.82 (0.46–1.47)
P = 0.187 P = 0.053 P = 0.318 P = 0.043 P = 0.510
Geohelminth infections
Negative 1.0 1.0 1.0 1.0 1.0
Positive 0.94 (0.55–1.62) 0.68 (0.32–1.47) 0.74 (0.44–1.23) 0.49 (0.23–1.04) 1.20 (0.63–2.26)
P = 0.828 P = 0.327 P = 0.238 P = 0.064 P = 0.581
Geohelminth ova/anti-Ascaris IgE
Ova -/IgE- 1.0 1.0 1.0 1.0 1.0
Ova +/IgE- 0.80 (0.33–1.91) 0.64 (0.10–3.99) 0.30 (0.04–2.31) – 1.02 (0.40–2.61)
P = 0.614 P = 0.628 P = 0.245 – P = 0.961
Ova -/ IgE+ 2.18 (1.08–4.42) 1.01 (0.40–2.54) 3.54 (1.48–8.45) 4.26 (1.35–13.39) 2.58 (1.13–5.91)
P = 0.030 P = 0.982 P = 0.005 P = 0.013 P = 0.025
Ova +/ IgE+ 2.03 (1.01–4.05) 0.94 (0.40–2.19) 3.36 (1.53–7.38) 3.73 (1.20–11.61) 2.39 (1.06–5.38)
P = 0.046 P = 0.885 P = 0.003 P = 0.023 P = 0.036
Statistically significant (P < 0.05) ORs are shown in bold. All wheeze outcomes refer to wheeze within the previous 12 months (recent wheeze).
Geohelminth ova or infections represent presence of ova of A. lumbricoides and/or T. trichiura. OR for 4-way analysis of Ova/IgE were adjusted
for a priori confounders only. ORs for two-level geohelminth exposures were adjusted for the following confounders: wheeze – age, sex, maternal
allergic disease, maternal smoking, maternal education, family income, birth order, excreta disposal, dog inside house currently and recent anthel-
minthic treatment; atopic markers – age, sex, maternal education, family income, birth order, excreta disposal and recent anthelminthic treatment.
Atopic wheeze was defined as wheeze within the previous 12 months in the presence of  0.70 kU/L of house dust mite and or cockroach.
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responsiveness [34] and female hormones have been
shown to increase the production of Th2-like cytokines
from peripheral blood mononuclear cells [35]. Leptin
has been proposed as one of the signals controlling
sexual maturation [36] and may also be involved in the
regulation of respiratory function [37]. Exposure to
important environmental exposures and the effects of
these on asthma phenotypes may vary by age [11].
The low PAF values for wheeze with respect to atopy
observed here (10.5% for asIgE and 10.0% for SPT) are
consistent with the findings of the ISAAC phase II study
that estimated PAFs for SPT of only 11% for both South
American study centres [14]. A possible explanation for
the low association between markers of atopy and wheeze
is exposure to factors that reduce atopy such as chronic
helminth infections that are potent regulators of immune
function [1, 20]. There was some evidence of a weaker
association between both markers of atopy and wheeze
among children with active geohelminth infections com-
pared with those without (SPT, OR 3.52 vs. OR 1.59; asIgE
OR 2.23 vs. OR 1.05 respectively). Geohelminth infections
with a pulmonary phase of larval migration of which
A. lumbricoides is the most relevant – the others being
hookworm and S. stercoralis that were of low prevalence
in our population – may, during chronic infections, atten-
uate the effects of atopy on pulmonary inflammation thus
reducing wheeze symptoms. The exclusively enteric para-
site, T. trichiura, may also have effects on inflammatory
responses at distal sites [38, 39].
In this study, anti-Ascaris IgE explained almost half
our cases of wheeze and this effect was independent of
asIgE, while active geohelminth infections did not
appear to affect the prevalence of wheeze. The presence
of anti-Ascaris IgE has been identified as a risk factor
for asthma and wheeze [40–42], and bronchial hyper-
reactivity [43–45] in previous studies. A possible expla-
nation could be cross-reactivity between allergens of A.
lumbricoides and invertebrates such as cockroach and
house dust mite. Cross-reactivity would be suggested to
be present if the effect of anti-Ascaris IgE on wheeze
disappeared when controlling for asIgE (i.e. the effect
of anti-Ascaris IgE on wheeze is considered to be medi-
ated by asIgE). This appeared to be the case in a previ-
ous study that demonstrated a strong association
between asthma and anti-Ascaris IgE in urban Costa
Rica where the prevalence of geohelminths was low
[45]. However, in another study conducted in rural Ban-
gladesh [41], anti-Ascaris IgE was shown to be a risk
factor for wheeze after adjusting for anti-mite IgE in a
population with a high prevalence of geohelminths.
Similarly in this study, although anti-Ascaris IgE was
strongly associated with asIgE, controlling for asIgE
had no effect on the association between anti-Ascaris
IgE and wheeze, indicating that the effect of anti-Asca-
ris IgE on wheeze was independent of asIgE.
There are limited data on the association between
markers of geohelminth infections and atopic and non-
atopic asthma/wheeze. Our data, from an area of high
geohelminth prevalence, showed active geohelminth
infections were not associated with wheeze, but that
anti-Ascaris IgE was a significant risk factor for both
atopic and non-atopic wheeze. Previous studies con-
ducted in areas of low geohelminth prevalence have
shown the presence of anti-Ascaris IgE, that may be
the only marker indicating the presence of geohelminth
infections [45], to be associated with atopic [40, 44, 45]
and non-atopic wheeze and asthma [27, 40]. Thus,
active infections with A. lumbricoides (in low preva-
lence areas) and the presence of anti-Ascaris IgE (irre-
spective of geohelminth prevalence) may be associated
with increased inflammation in the lungs causing
wheeze/asthma. The effect of A. lumbricoides exposures
on wheeze symptoms may vary by the prevalence of
infection: in communities with a low prevalence of
infection, the presence of active infections with this
parasite has been associated with more frequent symp-
toms of wheeze [19, 27, 46], while in areas of high
prevalence active infections do not appear to be associ-
ated with the prevalence of wheeze [18]. Possible expla-
nations for the association between anti-Ascaris IgE
and wheeze include: (1) Individuals with an atopic pre-
disposition are more likely to respond to Ascaris expo-
sures with an IgE response and are also at increased
risk of recent wheeze. In this study, we observed a simi-
lar association in atopics and non-atopics although the
association was stronger in atopics (2). The presence of
anti-Ascaris IgE may represent stronger protective
immunity to Ascaris [47]. Such protective immune
responses could cause pulmonary inflammation and
wheeze when targeted against Ascaris larvae migrating
through the lungs [19]. As protective immunity against
ascariasis in humans is not sterile, such an effect would
explain why the association between anti-Ascaris IgE
and wheeze was independent of the presence of eggs in
stool samples. (3) The presence of anti-Ascaris IgE may
be a marker for exposures to closely related zoonotic
infections such as A. suum and Toxocara canis with
which A. lumbricoides shares extensive immunological
cross-reactivity [48]. Human infections with Toxocara
and A. suum, causing visceral larva migrans, have been
associated with asthma-like symptoms [49–51]. Overall,
our observations point to the importance of the immu-
nological response to A. lumbricoides rather than the
presence per se of geohelminths, as an important deter-
minant of wheeze in our study population.
There are several limitations to this analysis that should
be considered. Firstly, we defined atopy to just two
dominant aeroallergens, house dust mite and cockroach.
In our study population, house dust mite and cockroach
are the most important environmental allergens when
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atopy is measured either by SPT or asIgE. An analysis of
SPT responses to seven relevant aeroallergens in the
cross-sectional study of 3960 children in which the pres-
ent case-control analysis was nested showed that only
3.1% of children with negative SPTs to mite and cock-
roach had positive SPTs to any of the other allergens
tested [18]. These results are consistent with those of pre-
vious studies from school children in Ecuador [52, 53].
With respect to asIgE, measurements were restricted to
D. pteronyssinus and P. americana based on the findings
of previous surveys conducted in similar populations in
Ecuador [15, 54]. A previous analysis of 50 plasma
samples from school children living in the study area of
specific IgE for D. pteronyssinus, P. americana, rye grass,
cat, and Aspergillus showed that none of the children
negative for D. pteronyssinus and P. americana were
positive for any of the other allergens (Cooper PJ et al.,
unpublished data). Similarly, the tropical mite, Blomia
tropicalis, does not appear to be an important sensitizing
mite in our population – a previous survey in the same
population showed a very low prevalence of SPT to this
mite (1.2%) and an analysis of mites and mite antigens in
dust samples showed that > 90% of mites were D. pter-
onyssinus and few dust samples had measurable levels of
Blo t 5, the dominant B. tropicalis allergen (Cooper PJ
et al., unpublished data). We can be confident that we
correctly identified most children with atopy. We used a
higher cut-off of  0.70 kU/L for positivity of tests for
specific IgE rather than the conventional cut-off of
 0.35 kU/L because of the possibility of false-positive
reactions at low titre that may be associated with the
extensive immunological cross-reactivity between hel-
minth allergens and aeroallergens [55, 56]. Secondly, we
used recent wheeze as a proxy for asthma. Wheeze cases
and non-wheeze controls were identified from parental
questionnaires based on that used in the ISAAC Phase 2
study [22] in which children with wheeze within the pre-
vious 12 months were identified and their status was con-
firmed by repeating the same questions approximately
2 years later. Viral respiratory tract infections (RTIs) are a
frequent cause of wheeze and are the major cause of
asthma exacerbations in children [57], and viral RTIs are
likely to be a significant cause of wheeze in our study
population. In this study, cases represented persistent
wheeze (at least one episode of wheeze in the previous
year on two occasions), which may be a better proxy for
asthma. EIB was used as a marker of the presence of
bronchial hyper-reactivity (BHR) at the time of evalua-
tion. Relatively, few wheeze cases had a positive exercise
test (14.2%) suggesting either that wheeze in our popula-
tion is mild and is not associated with significant BHR or
that this test may not be a good measure of BHR in the
conditions of high ambient humidity [58] present
throughout the year in the study area. Thirdly, given the
sample size, we had limited power for some of the
comparisons done, and cannot exclude the possibility of
type 2 statistical errors. However, we were able to detect
significant effects for the primary study exposures (age
and geohelminth exposures) and thus had sufficient power
for these associations. Lack of power may be a particular
issue in this study where tests for interaction were done –
only one of the interactions tested was statistically signifi-
cant. Fourthly, we did not measure acetaminophen use in
this study, an exposure that has been suggested recently to
have a role in the development of childhood asthma [59],
and cannot exclude residual confounding by acetamino-
phen use. Limited access to health care and a lack of com-
munity pharmacies in the study area may minimize such
bias. Finally, the case-control design of the study limits
our ability to infer causality or the direction of effects
between presumed exposures and outcomes.
In conclusion, our data from a case-control study of
wheezing illness in a rural area of tropical Ecuador has
provided evidence that most wheeze was not attribut-
able to atopy to house dust mite and cockroach,
although the association between atopy and wheeze did
appear to increase with age from childhood to adoles-
cence. We identified the presence of anti-Ascaris IgE as
an important risk factor for wheeze and this association
appeared to be independent of asIgE, and was observed
for both atopic and non-atopic wheeze. Active geo-
helminth infections were not associated with wheeze
although there was some evidence that active infections
reduced the association between atopy and wheeze.
Future studies will be necessary to identify the mecha-
nisms by which anti-Ascaris IgE may increase the prev-
alence of wheeze and could provide novel targets for
interventions either for the primary prevention or treat-
ment of asthma in childhood.
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